Anterix (ATEX) Revenue (2013 - 2026)

Anterix (ATEX) has reported Revenue for 14 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 38.08% year-over-year to $2.0 million; the trailing twelve-month figure through Jun 2026 stood at $7.0 million (up 18.86% YoY), and the FY2026 full-year result was $6.5 million, up 7.79% from the prior year.
• Revenue held at $2.0 million in Q2 2026 per ATEX's latest filing, from $2.0 million in the prior quarter.
• Across five years, Revenue topped out at $2.0 million in Q1 2026 and bottomed at $335000.0 in Q1 2022.
• Historically, Revenue has averaged $1.2 million across 5 years, with a median of $1.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Revenue surged 164.32% in 2023, then declined 7.02% in 2025.
• Over 5 years, Revenue stood at $578000.0 in 2022, then surged by 119.9% to $1.3 million in 2023, then advanced by 23.21% to $1.6 million in 2024, then grew by 0.45% to $1.6 million in 2025, then increased by 24.48% to $2.0 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $2.0 million, $2.0 million, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.